Niacin is Used for treating hyperlipidemia by dosing once daily in the evening or at night to reduce elevated total cholesterol, LDL cholesterol, and triglyceride levels, and increase HDL cholesterol levels. It was first introduced by Medpointe Pharmaceuticals Medpointe Healthcare Inc in its drug Wampocap on Approved Prior to Jan 1, 1982. Other drugs containing Niacin are Niaspan, Niaspan Titration Starter Pack. 29 different companies have introduced drugs containing Niacin.

Niacin Patents

Given below is the list of patents protecting Niacin, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Niaspan	US6469035	Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid	Mar 15, 2018 (Expired)	Abbvie
Niaspan	US6080428	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor	May 27, 2017 (Expired)	Abbvie
Niaspan Titration Starter Pack	US6080428	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor	May 27, 2017 (Expired)	Abbvie
Niaspan	US6818229	Intermediate release nicotinic acid compositions for treating hyperlipidemia	Feb 15, 2014 (Expired)	Abbvie
Niaspan	US6129930	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night	Sep 20, 2013 (Expired)	Abbvie
Niaspan	US6406715	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles	Sep 20, 2013 (Expired)	Abbvie
Niaspan	US6676967	Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia	Sep 20, 2013 (Expired)	Abbvie
Niaspan	US6746691	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics	Sep 20, 2013 (Expired)	Abbvie
Niaspan	US6818229	Intermediate release nicotinic acid compositions for treating hyperlipidemia	Sep 20, 2013 (Expired)	Abbvie
Niaspan	US7011848	Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor	Sep 20, 2013 (Expired)	Abbvie
Niaspan	US7998506	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor	Sep 20, 2013 (Expired)	Abbvie
Niaspan Titration Starter Pack	US6129930	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night	Sep 20, 2013 (Expired)	Abbvie
Niaspan Titration Starter Pack	US6406715	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles	Sep 20, 2013 (Expired)	Abbvie
Niaspan Titration Starter Pack	US6746691	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics	Sep 20, 2013 (Expired)	Abbvie
Niaspan Titration Starter Pack	US7011848	Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor	Sep 20, 2013 (Expired)	Abbvie

Add above patents to watchlist

Niacin's Family Patents

Full family tree

Niacin Generic API Manufacturers

Several generic applications have been filed for Niacin. The first generic version for Niacin was by Everylife and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Mpp Pharma Llc and was approved on Jul 25, 2025.

Given below is the list of companies who have filed for Niacin generic, along with the locations of their manufacturing plants worldwide.